Literature DB >> 3264691

Lymphocytotoxic autoantibodies in progressive systemic sclerosis.

K Herrmann1, J Schaller, U F Haustein, C Baldauf, S Kiessig.   

Abstract

In 53 patients with progressive systemic sclerosis (PSS) the lymphocytotoxic activity of their serum was measured in a microlymphocytotoxicity assay. In 21 of the 53 patients the test reacted distinctly positively in the heterologous system, and in 9 of these 21 also in the autologous system. After preparation of the immunoglobulins from these positive sera, whole cytotoxic activity was detected only in the IgM fraction but not in the IgG fraction. When using prepared T lymphocytes as target cells in the microlymphocytotoxicity test, the cytotoxic activity of the positive PSS sera showed itself to be directed against this lymphocyte population. Further analysis using the Western-blot technique showed that the IgM autoantibody in PSS sera reacted with the cell surface of CD4+ lymphocytes. The cross reactivity with extractable nuclear antigens was rather improbable. These results suggest that lymphocytotoxic autoantibodies may play a role in immunological disturbances in PSS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264691     DOI: 10.1007/bf00429977

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  27 in total

1.  Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome.

Authors:  D L TUFFANELLI
Journal:  Am J Med Sci       Date:  1962-02       Impact factor: 2.378

2.  In vivo helper activity of autoreactive T cell clones.

Authors:  K Tomonari
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Autoantibodies to fibroblasts in scleroderma.

Authors:  T J Brentnall; D Kenneally; A J Barnett; H J de Aizpurua; S J Lolait; R Ashcroft; B H Toh
Journal:  J Clin Lab Immunol       Date:  1982-05

5.  Abnormalities of immunoregulation in progressive systemic sclerosis. Evidence for excess helper-cell function and altered B-cell function.

Authors:  R S Krakauer; J Sundeen; D N Sauder; A Scherbel
Journal:  Arch Dermatol       Date:  1981-02

6.  Anticentromere and anticentriole antibodies in the scleroderma spectrum.

Authors:  D L Tuffanelli; F McKeon; D M Kleinsmith; T K Burnham; M Kirschner
Journal:  Arch Dermatol       Date:  1983-07

7.  Cytotoxicity of sera from patients with scleroderma. Effects on human endothelial cells and fibroblasts in culture.

Authors:  S Cohen; A R Johnson; E Hurd
Journal:  Arthritis Rheum       Date:  1983-02

8.  Subset specificity of antilymhocyte antibodies in systemic lupus erythematosus. II. Preferential reactivity with T4 + cells is associated with relative depletion of autologous T4 + cells.

Authors:  J B Winfield; M Shaw; A Yamada; S Minota
Journal:  Arthritis Rheum       Date:  1987-02

9.  Immunofluorescence studies in progressive systemic sclerosis (scleroderma) and mixed connective tissue disease.

Authors:  G Reimer; U Huschka; J Keller; R Kammerer; O P Hornstein
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

10.  Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin.

Authors:  E Cairns; J Block; D A Bell
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.